Stephane Bancel Moderna, Inc. (MRNA) insider trading activity

Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $156 Million. The most recent transaction as insider was on Jun 09, 2022, when has been sold 40,000 shares (Common Stock) at a price of $0.99 per share, resulting in proceeds of $39,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M

0.12% 3M change

0.62% 12M change

Total Value Held $156 Million

Stephane Bancel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 08 2022	SELL Open market or private sale	$6,002,800 $150.07 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 08 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 02 2022	SELL Open market or private sale	$5,420,000 $135.5 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 02 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 01 2022	SELL Open market or private sale	$5,801,200 $145.03 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 01 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
May 26 2022	SELL Open market or private sale	$5,308,000 $132.7 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
May 26 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
May 25 2022	SELL Open market or private sale	$5,159,200 $128.98 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
May 25 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
May 18 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,411,946 Common Stock
May 16 2022	BUY Other acquisition or disposition	-	24,411 Added 0.45%	5,415,946 Common Stock
May 11 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,391,535 Common Stock
May 11 2022	SELL Open market or private sale	$1,158,570 $128.73 p/Share	9,000 Reduced 0.17%	5,395,535 Common Stock
May 04 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,404,535 Common Stock
May 04 2022	SELL Open market or private sale	$1,342,170 $149.13 p/Share	9,000 Reduced 0.17%	5,408,535 Common Stock
Apr 27 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,417,535 Common Stock
Apr 27 2022	SELL Open market or private sale	$1,283,760 $142.64 p/Share	9,000 Reduced 0.17%	5,421,535 Common Stock
Apr 20 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,430,535 Common Stock
Apr 20 2022	SELL Open market or private sale	$1,351,530 $150.17 p/Share	9,000 Reduced 0.17%	5,434,535 Common Stock
Apr 13 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,452,407 Common Stock
Apr 13 2022	SELL Open market or private sale	$1,520,820 $168.98 p/Share	9,000 Reduced 0.17%	5,443,535 Common Stock
Apr 06 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,456,535 Common Stock
Apr 06 2022	SELL Open market or private sale	$1,432,440 $159.16 p/Share	9,000 Reduced 0.16%	5,460,535 Common Stock

Stephane Bancel

Chief Executive Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account